Your shopping cart is currently empty

NEDD4-IN-1 (Compound 32) is a potent inhibitor of NEDD4, with an IC50 of 0.12 μM. It demonstrates significant antiproliferative activity in the H292 cell line and exhibits high plasma protein binding and moderate to high in vitro clearance in both human and mouse models. The compound shows exceptional stability in mouse plasma, alongside excellent efficacy, selectivity, and favorable in vitro ADME properties. In mouse models, its systemic plasma clearance surpasses hepatic blood flow. NEDD4-IN-1 is applicable for anticancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NEDD4-IN-1 (Compound 32) is a potent inhibitor of NEDD4, with an IC50 of 0.12 μM. It demonstrates significant antiproliferative activity in the H292 cell line and exhibits high plasma protein binding and moderate to high in vitro clearance in both human and mouse models. The compound shows exceptional stability in mouse plasma, alongside excellent efficacy, selectivity, and favorable in vitro ADME properties. In mouse models, its systemic plasma clearance surpasses hepatic blood flow. NEDD4-IN-1 is applicable for anticancer research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.